Eliem Therapeutics GAAP EPS of -$0.13

Seeking Alpha11/15 01:45

Climb Bio Q3 EPS $(0.13) Up From $(0.15) YoY

Benzinga11/13 06:15

Climb Bio 3Q Loss/Shr 13c >CLYM

Dow Jones11/13 05:49

Press Release: Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Dow Jones11/13 05:05

クライム・バイオ | 10-Q：Q3 2024 四半期報告書

SEC11/13 05:03

Climb Bio Shares Are Trading Higher. The Company Announced It Appointed a New Chair to Its Board of Directors.

Benzinga11/11 23:37